Lansopram (Lansoprazole)

Lansoprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This blocks the final step of acid secretion, leading to a marked and sustained reduction in gastric acidity, which promotes healing of acid‑related lesions.

The appropriate dose of Lansopram is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for lansoprazole during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Lansopram, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lansopram (lansoprazole) is comparable to other proton pump inhibitors such as omeprazole, esomeprazole and pantoprazole in efficacy for acid suppression. Differences may exist in pharmacokinetic profiles, drug‑interaction potential and dosing frequency, which clinicians consider when selecting the most appropriate PPI for a patient.

Lansopram tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Lansopram is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the medication before a meal, but patients should follow the specific instructions provided by their prescriber.

Serious adverse reactions to Lansopram can include severe allergic responses such as anaphylaxis, Clostridioides difficile‑associated colitis, interstitial nephritis, significant electrolyte disturbances like low magnesium, and rare skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if these occur.

Lansopram should be avoided in patients with known hypersensitivity to lansoprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic gastric environment, and patients with a history of certain infections or kidney impairment.